9 IPOs priced deals this week. This brings April’s total to 20, making it the busiest month of the past 22. These 20 pricings were almost enough to double the count for the year, raising that number to 45. Five biotechs priced in April, doubling the total...read more
Catasys, which provides substance abuse, depression and anxiety outpatient programs, raised $15 million by offering 3.1 million shares at $4.80, below the OTC close of $10.00. Catasys plans to list on the Nasdaq under the symbol CATS. Joseph Gunnar & Co....read more
Catasys, which provides substance abuse, depression and anxiety outpatient programs, announced terms for its IPO on Monday. The Los Angeles, CA-based company plans to raise $15 million by offering 1.8 million shares at a price of $8.40. At the proposed...read more
Catasys, which provides substance abuse, depression and anxiety outpatient programs, filed on Friday with the SEC to raise up to $15 million in an initial public offering. Shares of the company are listed on the OTCQB Marketplace and finished Friday at $1.30.
...read more
US IPO Weekly Recap: Floor & Décor pops 53%, Carvana skids 26%
9 IPOs priced deals this week. This brings April’s total to 20, making it the busiest month of the past 22. These 20 pricings were almost enough to double the count for the year, raising that number to 45. Five biotechs priced in April, doubling the total...read more
Micro-cap substance abuse program provider Catasys prices Nasdaq uplisting at $4.80
Catasys, which provides substance abuse, depression and anxiety outpatient programs, raised $15 million by offering 3.1 million shares at $4.80, below the OTC close of $10.00. Catasys plans to list on the Nasdaq under the symbol CATS. Joseph Gunnar & Co....read more
Catasys, a micro-cap substance abuse program provider, sets terms for $15 million IPO
Catasys, which provides substance abuse, depression and anxiety outpatient programs, announced terms for its IPO on Monday. The Los Angeles, CA-based company plans to raise $15 million by offering 1.8 million shares at a price of $8.40. At the proposed...read more
Catasys, a micro-cap substance abuse outpatient program provider, files for a $15 million Nasdaq uplisting
Catasys, which provides substance abuse, depression and anxiety outpatient programs, filed on Friday with the SEC to raise up to $15 million in an initial public offering. Shares of the company are listed on the OTCQB Marketplace and finished Friday at $1.30. ...read more